172 related articles for article (PubMed ID: 17586555)
1. Emerging biological therapies in primary Sjogren's syndrome.
Ramos-Casals M; Brito-Zerón P
Rheumatology (Oxford); 2007 Sep; 46(9):1389-96. PubMed ID: 17586555
[TBL] [Abstract][Full Text] [Related]
2. Biologic treatment in Sjögren's syndrome.
Sada PR; Isenberg D; Ciurtin C
Rheumatology (Oxford); 2015 Feb; 54(2):219-30. PubMed ID: 25342375
[TBL] [Abstract][Full Text] [Related]
3. The management of Sjögren's syndrome.
Mavragani CP; Moutsopoulos NM; Moutsopoulos HM
Nat Clin Pract Rheumatol; 2006 May; 2(5):252-61. PubMed ID: 16932698
[TBL] [Abstract][Full Text] [Related]
4. Emerging biotherapies for Sjögren's syndrome.
Tobón GJ; Saraux A; Pers JO; Youinou P
Expert Opin Emerg Drugs; 2010 Jun; 15(2):269-82. PubMed ID: 20384543
[TBL] [Abstract][Full Text] [Related]
5. B cell-targeted therapies in Sjögren's syndrome.
Tobón GJ; Pers JO; Youinou P; Saraux A
Autoimmun Rev; 2010 Feb; 9(4):224-8. PubMed ID: 19671451
[TBL] [Abstract][Full Text] [Related]
6. Sjögren's syndrome in dermatology.
Fox RI; Liu AY
Clin Dermatol; 2006; 24(5):393-413. PubMed ID: 16966020
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential for B-cell modulation in Sjögren's syndrome.
Mariette X
Rheum Dis Clin North Am; 2008 Nov; 34(4):1025-33, x. PubMed ID: 18984420
[TBL] [Abstract][Full Text] [Related]
8. The future of B cell-targeted therapies in Sjögren's syndrome.
Cornec D; Saraux A; Devauchelle-Pensec V; Clodic C; Pers JO
Immunotherapy; 2013 Jun; 5(6):639-46. PubMed ID: 23725286
[TBL] [Abstract][Full Text] [Related]
9. Treatment of the patient with Sjögren's syndrome.
Fox RI
Rheum Dis Clin North Am; 1992 Aug; 18(3):699-709. PubMed ID: 1496169
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of Sjögren's syndrome and therapeutic consequences.
Mariette X; Gottenberg JE
Curr Opin Rheumatol; 2010 Sep; 22(5):471-7. PubMed ID: 20671520
[TBL] [Abstract][Full Text] [Related]
11. B-cell depletion in autoimmune diseases. Advances in autoimmunity.
Guzman Moreno R
Autoimmun Rev; 2009 Jun; 8(7):585-90. PubMed ID: 19393204
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune diseases and Sjogren's syndrome: an autoimmune exocrinopathy.
Fox PC
Ann N Y Acad Sci; 2007 Mar; 1098():15-21. PubMed ID: 17332090
[TBL] [Abstract][Full Text] [Related]
13. Primary Sjögren's syndrome: new clinical and therapeutic concepts.
Ramos-Casals M; Tzioufas AG; Font J
Ann Rheum Dis; 2005 Mar; 64(3):347-54. PubMed ID: 15498797
[TBL] [Abstract][Full Text] [Related]
14. Biological therapies in primary Sjögren's syndrome.
Ng WF; Bowman SJ
Expert Opin Biol Ther; 2011 Jul; 11(7):921-36. PubMed ID: 21457124
[TBL] [Abstract][Full Text] [Related]
15. Biologic treatments in Sjögren's syndrome.
Bowman S; Barone F
Presse Med; 2012 Sep; 41(9 Pt 2):e495-509. PubMed ID: 22836195
[TBL] [Abstract][Full Text] [Related]
16. Sjögren's syndrome: Old and new therapeutic targets.
Mavragani CP; Moutsopoulos HM
J Autoimmun; 2020 Jun; 110():102364. PubMed ID: 31831255
[TBL] [Abstract][Full Text] [Related]
17. New biological therapies in Sjögren's syndrome.
Nocturne G; Cornec D; Seror R; Mariette X
Best Pract Res Clin Rheumatol; 2015 Dec; 29(6):783-93. PubMed ID: 27107513
[TBL] [Abstract][Full Text] [Related]
18. Rituximab in primary Sjögren's syndrome: a ten-year journey.
Carubbi F; Alunno A; Cipriani P; Bartoloni E; Ciccia F; Triolo G; Gerli R; Giacomelli R
Lupus; 2014 Nov; 23(13):1337-49. PubMed ID: 25096066
[TBL] [Abstract][Full Text] [Related]
19. Advances in the diagnosis and treatment of Sjogren's syndrome.
Chen X; Wu H; Wei W
Clin Rheumatol; 2018 Jul; 37(7):1743-1749. PubMed ID: 29804149
[TBL] [Abstract][Full Text] [Related]
20. New approaches in Sjögren's syndrome therapy.
Ramos-Casals M; Brito-Zerón P
Expert Rev Clin Immunol; 2007 Mar; 3(2):195-204. PubMed ID: 20477108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]